Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pulmonary thromboembolic events in COVID-19-A systematic literature review.
Overton PM, Toshner M, Mulligan C, Vora P, Nikkho S, de Backer J, Lavon BR, Klok FA; PVRI Innovative Drug Development Initiative. Overton PM, et al. Among authors: nikkho s. Pulm Circ. 2022 Jul 1;12(3):e12113. doi: 10.1002/pul2.12113. eCollection 2022 Jul. Pulm Circ. 2022. PMID: 35942076 Free PMC article. Review.
Repurposing of medications for pulmonary arterial hypertension.
Toshner M, Spiekerkoetter E, Bogaard H, Hansmann G, Nikkho S, Prins KW. Toshner M, et al. Among authors: nikkho s. Pulm Circ. 2020 Nov 18;10(4):2045894020941494. doi: 10.1177/2045894020941494. eCollection 2020 Oct-Dec. Pulm Circ. 2020. PMID: 33282182 Free PMC article. Review.
Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study.
McLaughlin VV, Jansa P, Nielsen-Kudsk JE, Halank M, Simonneau G, Grünig E, Ulrich S, Rosenkranz S, Gómez Sánchez MA, Pulido T, Pepke-Zaba J, Barberá JA, Hoeper MM, Vachiéry JL, Lang I, Carvalho F, Meier C, Mueller K, Nikkho S, D'Armini AM. McLaughlin VV, et al. Among authors: nikkho s. BMC Pulm Med. 2017 Dec 28;17(1):216. doi: 10.1186/s12890-017-0563-7. BMC Pulm Med. 2017. PMID: 29282032 Free PMC article. Clinical Trial.
Effect of riociguat on pulmonary arterial compliance in the PATENT and CHEST studies.
Thenappan T, Al-Naamani N, Ghio S, Ghofrani HA, Hassoun PM, Pritzker M, Torbicki A, Nikkho S, Busse D, Preston IR. Thenappan T, et al. Among authors: nikkho s. Pulm Circ. 2020 Nov 20;10(4):2045894020963836. doi: 10.1177/2045894020963836. eCollection 2020 Oct-Dec. Pulm Circ. 2020. PMID: 33282192 Free PMC article.
Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working Group.
Morland K, Gerges C, Elwing J, Visovatti SH, Weatherald J, Gillmeyer KR, Sahay S, Mathai SC, Boucly A, Williams PG, Harikrishnan S, Minty EP, Hobohm L, Jose A, Badagliacca R, Lau EMT, Jing ZC, Vanderpool RR, Fauvel C, Leonidas Alves J Jr, Strange G, Pulido T, Qian J, Li M, Mercurio V, Zelt JGE, Moles VM, Cirulis MM, Nikkho SM, Benza RL, Elliott CG. Morland K, et al. Among authors: nikkho sm. Pulm Circ. 2023 Dec 21;13(4):e12317. doi: 10.1002/pul2.12317. eCollection 2023 Oct. Pulm Circ. 2023. PMID: 38144948 Free PMC article.
Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension study.
Halank M, Hoeper MM, Ghofrani HA, Meyer FJ, Stähler G, Behr J, Ewert R, Fletcher M, Colorado P, Nikkho S, Grimminger F. Halank M, et al. Among authors: nikkho s. Respir Med. 2017 Jul;128:50-56. doi: 10.1016/j.rmed.2017.05.008. Epub 2017 May 16. Respir Med. 2017. PMID: 28610669 Free article. Clinical Trial.
31 results